Comparative study of oral iron and intravenous iron sucrose for the treatment of iron deficiency anemia in pregnancy
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20164652Keywords:
Hemoglobin, Iron sucrose, Iron deficiency anemia, Oral Ferrous SulphateAbstract
Background: The aim of this study was to compare the efficacy and safety of iron sucrose with oral iron in the treatment of iron deficiency anemia of pregnancy.
Methods: An interventional comparative study was conducted at Jhalawar Medical College, Jhalawar involving 80 pregnant women with iron deficiency anemia from March 2016 to August 2016. Inclusion criteria were gestational age between 24-32 weeks with established iron deficiency anemia, with hemoglobin between 7-10g/dl. Target Hemoglobin was 11 g/dl. In intravenous iron sucrose group iron sucrose dose was calculated from following formula: total iron dose required (mg) = 2.4 x body weight in Kg x (target Hb – Patient’s Hb g/dl) + 500. In oral iron, group patient received ferrous-sulphate 335 mg daily BD. Hb level were reviewed at 2, 4, 6 weeks.
Results: Change in Hemoglobin level from baseline significantly higher in IV iron group than oral iron group. In IV iron, group mean value of baseline Hb was 8.07±0.610 g/dl and in oral iron group was 8.48±0.741 g/dl. At the end of 6-week mean hemoglobin in IV iron sucrose was 10.66±0.743 g/dl and in oral iron group was 10.08±0.860 g/dl.
Conclusions: Intravenous iron sucrose elevates more Hb than oral iron, with less adverse effects.
References
De benoist B. (eds). Worldwide Prevalance of anemia 19993-2005. WHO Global Database on Anemia Geneva, World Health Organization, 2008.
Addressing India’s Nutrition Challenges. Report of the Multistake holder Retreat. Planning Commission, Government of India. 2011.
Center for Disease Control and Prevention. CDC criteria for anemia in children and childbearing-aged women .Morb Moral Wkly Rep. 1989;38:400.
Candio F, Hofmeyr GJ. Treatments for iron deficiency anemia in pregnancy. RHL commentary. The WHO Reproductive Health Library. Geneva: World Health Organization; 2007.
UNICEF/UNO/WHO. Iron deficiency anemia: World Health Organization; 2001.
Ian Donald’s practical obstetric problems, seventh edition, 2014:198.
Maternal Mortality in India 1997-2003, Registrar General of India. Available from: http://www.censusindia.net/. Accessed on December 15, 2008.
Breyman C. Iron deficiency and anemia in pregnancy: Modern aspects of diagnosis and therapy. Blood Cells Mol Dis. 2002;29:506-16.
Breymann C; Anemia working group. Current aspects of diagnosis and therapy of iron deficiency anemia in pregnancy. Schweiz Rundsch Med Prax. 2001;90:1283-91.
Toteja GS, Singh P. Micronutrient profile of Indian Population. New Delhi: Indian Council of Medical Research; 2004.
Bayoumeu F, Subiran-Buisset C, Baka NE, Legagneur H, Monnier-Barbarino P, Lax-enaire MC. Iron therapy in iron deficiency nemia in pregnancy: Intravenous route versus oral route. Am J Obstet Gynecol. 2002;186:518-22.
Perewusny KG, Huck R, Huck A, Brey-mann C. Parenteral iron-sucrose complex. Br J Nutr. 2002;88:3-10.
Al-Momen AK, al-Meshari A, al-Nuaim L, Saddique A, Abutalib Z, Khashogi T, et al. Intravenous iron sucrose complex in the treatment of iron deficiency anemia during pregnancy. Eur J Obstet Gynecol Reprod Biol. 1996;69:121-4.
Deeba S, Purandare Shekhar V, Sathe AV. Iron deficiency anemia in pregnancy: Intravenus verus oral route. Journal of Obstetrics and Gynecology of India. 2012;62(3):317-321.
